10:46 AM EST - Field Trip Health Ltd. : Will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). The announcement follows amendments to the SAP announced in the Canada Gazette on January 5, which have enabled physicians in Canada to make applications to Health Canada for access to “restricted drugs”, including psilocybin and MDMA. Field Trip Health Ltd.
shares T.FTRP are trading down $0.09 at $2.72.
